Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
DNA X, Inc. (SONM) had Cost of Goods Sold of $-33.11M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-8.89M |
|
|
Cost of Goods Sold |
$-33.11M |
$33.11M |
|
$-48.79M |
|
$48.79M |
|
$-1.21M |
|
$3.45M |
|
$3.45M |
|
$3.81M |
|
$3.81M |
|
$-8.89M |
|
$3.81M |
|
$4.66M |
|
$50.28M |
|
0.72M |
|
0.72M |
|
$-10.98 |
|
$-10.98 |
|
| Balance Sheet Financials | |
$28.91M |
|
-- |
|
$14.99M |
|
$43.90M |
|
$48.03M |
|
-- |
|
$3.83M |
|
$51.85M |
|
$-7.96M |
|
$-7.96M |
|
$-7.96M |
|
1.27M |
|
| Cash Flow Statement Financials | |
$-23.53M |
|
-- |
|
$19.49M |
|
$5.34M |
|
$1.30M |
|
$-4.04M |
|
$1.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.60 |
|
-- |
|
-- |
|
-- |
|
-0.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-47.96% |
|
-47.96% |
|
8.69% |
|
-47.96% |
|
$-6.29 |
|
$-32.55 |
|
$-32.55 |
|